Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel H Kwon

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
European Urology Focus|January 23, 2023
Intermittent Hormonal Therapy in Biochemical Recurrence of Prostate Cancer Is Worth Considering Because of Mitigation of Cardiovascular Events and Reduction of Other EffectsDaniel H Kwon, Rahul R Aggarwal
European Urology|September 22, 2020
Does One Size Fit All? Re-evaluating Prostate-specific Antigen Progression Thresholds for Clinical TrialsDaniel H Kwon, Terence W Friedlander
European Urology|March 16, 2021
Untangling the PROfound Trial for Advanced Prostate Cancer: Is There Really a Role for Olaparib?Daniel H Kwon, Christopher M Booth, Vinay Prasad
JAMA Oncology|July 13, 2023
FDG PET Scans in Cancer CareHenry K Litt, Daniel H Kwon, Ana I Velazquez
JAMA Oncology|October 6, 2022
PSMA PET ScanDaniel H Kwon, Ana I Velazquez, Ivan de Kouchkovsky
Radiologic Clinics of North America|October 24, 2025
The Current Role of Renal Mass BiopsyLuyao Shen, Daniel H Kwon, Geoffrey A Sonn, et al.
JCO Oncology Practice|December 17, 2020
Prime Time for Consultation Audio Recordings: Supporting Shared Decision Making During and After the COVID-19 EraDaniel H Kwon, Rahul R Aggarwal, Laura J Esserman, et al.
Urologic Oncology|July 2, 2024
Accuracy, readability, and quality of websites about metastatic renal cell carcinoma treatmentNonna Shakhnazaryan, Liam Gima-Lange, Arpita Desai, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 29, 2024
Shared decision-making needs, barriers, and facilitators of patients with newly diagnosed advanced cancer in the hospital: a multi-level, mixed-methods studyKevin R Reyes, Paul Wong, Mary Petrofsky, et al.
Urologic Oncology|June 24, 2022
Skeletal-related events after abiraterone or enzalutamide in patients with metastatic castration-resistant prostate cancer: A population-based study using the SEER-Medicare linked datasetDaniel H Kwon, Alan Paciorek, Li Zhang, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
European Urology Focus|January 23, 2023
Intermittent Hormonal Therapy in Biochemical Recurrence of Prostate Cancer Is Worth Considering Because of Mitigation of Cardiovascular Events and Reduction of Other EffectsDaniel H Kwon, Rahul R Aggarwal
European Urology|September 22, 2020
Does One Size Fit All? Re-evaluating Prostate-specific Antigen Progression Thresholds for Clinical TrialsDaniel H Kwon, Terence W Friedlander
European Urology|March 16, 2021
Untangling the PROfound Trial for Advanced Prostate Cancer: Is There Really a Role for Olaparib?Daniel H Kwon, Christopher M Booth, Vinay Prasad
JAMA Oncology|July 13, 2023
FDG PET Scans in Cancer CareHenry K Litt, Daniel H Kwon, Ana I Velazquez
JAMA Oncology|October 6, 2022
PSMA PET ScanDaniel H Kwon, Ana I Velazquez, Ivan de Kouchkovsky
Radiologic Clinics of North America|October 24, 2025
The Current Role of Renal Mass BiopsyLuyao Shen, Daniel H Kwon, Geoffrey A Sonn, et al.
JCO Oncology Practice|December 17, 2020
Prime Time for Consultation Audio Recordings: Supporting Shared Decision Making During and After the COVID-19 EraDaniel H Kwon, Rahul R Aggarwal, Laura J Esserman, et al.
Urologic Oncology|July 2, 2024
Accuracy, readability, and quality of websites about metastatic renal cell carcinoma treatmentNonna Shakhnazaryan, Liam Gima-Lange, Arpita Desai, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 29, 2024
Shared decision-making needs, barriers, and facilitators of patients with newly diagnosed advanced cancer in the hospital: a multi-level, mixed-methods studyKevin R Reyes, Paul Wong, Mary Petrofsky, et al.
Urologic Oncology|June 24, 2022
Skeletal-related events after abiraterone or enzalutamide in patients with metastatic castration-resistant prostate cancer: A population-based study using the SEER-Medicare linked datasetDaniel H Kwon, Alan Paciorek, Li Zhang, et al.
Pageof 4